BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 16, 2011
View Archived Issues
European IPO Window Open? Philogen Files $89.6M Offering
Read More
Surface Alterations to Bacteria Affect Their Ability to Spread
Read More
Phase4 Ventures' Life Science Holdings Sold to HarbourVest
Read More
Medivir Inks Infectious Disease Pact with Janssen Pharmaceutica
Read More
Clavis Conducts Pancreatic Cancer Biomarker Study
Read More
Other News To Note
Read More
eTherapeutics Raises $33.6M, London's Invesco to Own 47.7%
LONDON – eTherapeutics plc achieved the seemingly impossible, raising £21 million (US$33.6 million) in a placment at a premium to the closing price on Monday, the day before the deal was announced. (BioWorld International)
Read More
Renovo's Juvista Tanks in Phase III; Stock plunges 75%
Read More